search
Back to results

Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings (PainPac)

Primary Purpose

Colorectal Cancer

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
PainPac
Sponsored by
Duke University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Colorectal Cancer focused on measuring cancer, pain, coping, mHealth, symptom management

Eligibility Criteria

18 Years - 110 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Stage I-IV Colorectal Cancer diagnosis 18 years of age or older Exclusion Criteria: Cognitive Impairment Brain Metastases Severe psychiatric condition (e.g., psychosis) that would contraindicate safe participation Participation in behavioral pain management in the past 6 months.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    PainPac

    PCST-Video

    Arm Description

    4 behavioral cancer pain intervention sessions delivered by mobile application. Patient-focused intervention. PainPac uses Social Cognitive Theory to promote behaviors to improve pain, self-efficacy for pain management, and pain-related quality of life indices. It also uses real-time data to personalize the intervention and messaging to participants. The app also has interactive components to improve coping skills engagement.

    4 behavioral cancer pain intervention sessions delivered by videoconferencing by a pain therapist in the medical center to the patient in their natural environment (e.g., home). Sessions will be scheduled weekly for 45-60 min and mimic in person sessions. PCST-Video session content is matches the PainPac skills modules. PCST-Video participants will complete assessments at the same intervals as PainPac participants.

    Outcomes

    Primary Outcome Measures

    Feasibility as measured by study accrual
    Reaching target accrual (N=60) within 15 months.
    Feasibility as measured by attrition
    <25% attrition by 1-month post-baseline.
    Feasibility as measured by the number of study baseline assessments completed
    Protocol adherence indicated by calculating the degree to which participants are willing/able to complete the study baseline assessment.
    Feasibility as measured by the number of post-study sessions assessments completed
    Protocol adherence indicated by calculating the degree to which participants are willing/able to complete the post-study sessions assessment.
    Feasibility as measured by the number of study 1-month follow up assessments completed
    Protocol adherence indicated by calculating the degree to which participants are willing/able to complete the 1-month follow up assessment.
    Feasibility of PainPac
    Includes protocol adherence indicated by calculating the degree to which participants are willing/able to complete the 4 PainPac skills modules or 4 PCST-Video sessions.

    Secondary Outcome Measures

    Acceptability as measured by the Client Satisfaction Questionnaire.
    10-item Client Satisfaction Questionnaire (CSQ). This questionnaire contains 10 items rated from 1=low acceptability to 4=high acceptability; scores are created by utilizing the Likert Scale to average Client Satisfaction Questionnaire answers resulting in a score range from 1-4. The participant will complete this acceptability questionnaire as part of the post-session follow up assessment.
    Acceptability as measured by Atkinson's tool of mHealth innovations.
    Atkinson's tool will also be used to assess perceived attributes of mHealth innovations. Tool has 30 items about mHealth, participant indicates their level of agreement or disagreement on a 6-point Likert scale: l=strongly agree, 2=agree, 3=somewhat agree, 4=somewhat disagree. 5=disagree, and 6=strongly disagree.
    PainPac Patient Preferences, Barriers, Facilitators, Attitudes, and Beliefs
    Post-intervention, measured together as one measure, patients will be asked 10 items modeled from labs previous work. Items will be answered on a 0-10 scale with 0=low preference, barrier, belief and 10=high preference, barrier, belief.
    Change in Computer Self-Efficacy
    Post-Intervention, 10 items on a 10 point scale from 0=not at all confident to 10=completely confident. Patients are asked 10 items regarding their confidence in ability to use technology (computer and smartphone app).
    Change in Pain Severity as Assessed With the Brief Pain Inventory (BPI)
    Pain will be assessed with the Brief Pain Inventory (BPI). Patients will rate their "worst", "least", "average", and "now" pain from 0=no pain to 10=worst pain imaginable. An average of the responses to these items is used to create a single pain severity score.
    Pain Interference as Assessed With the Brief Pain Inventory (BPI) - Pain Interference Scale
    Pain interference will be assessed with the Brief Pain Inventory (BPI) - Pain Interference Scale. Patients will rate how much pain interfered with a variety of activities and mood states over the last 7 days from 0=does not interfere to 10=completely interferes. An average of the responses to these items is used to create a single pain severity score.
    Change in Pain Self-Efficacy for Pain Management
    5-item self-efficacy subscale of the Chronic Pain Self-Efficacy Scale. Items ask about patients' certainty about pain control, pain during activities, and reducing pain without extra medication using a 10=very uncertain to 100=very certain scale and averaged. The 10-item Computer Self-Efficacy Scale will be used to ask about patients' confidence in using technology to receive a behavioral pain intervention.
    Change in Patient Burden
    12-item measure developed in the lab through a NCI study examining burdens with accessing care after a cancer diagnosis. Patients will rate difficulty completing the intervention (PainPac modules or PCST-Video sessions) on a 1=not at all to 5=very much scale based on physical, emotional, financial burdens. A summated scale will be used to assess internal validity using Cronbach's alpha of 0.75.
    Engagement in Study
    Engagement is defined as the number of times/week participants log into PainPac and practice the skills. Engagement will be assessed based on app data and patient self-report. Patient Engagement will be assessed by electronic app data (e.g., PainPac weekly log-ins) and patient self-report defined as the number of times per week they practice the coping skills. >3 times/week will serve as the benchmark; if participants log into PainPac and/or practice the coping skills <3 times/week, PainPac will not be considered engaging.
    Change in Quality of Life
    Centers for Disease Control Health Related Quality of Life 14-item measure. This measure assesses healthy days in the last month and activity limitations and symptoms.
    Change in PROMIS - Emotional Distress (Depression) Short Form
    Post-intervention and 1-month follow up, 8 items on a 5 point scale from 1=never, 2=rarely, 3=sometimes, 4=often, 5=always. Patients are asked 8-items regarding "in the past 7 days I felt..." to assess their emotional distress levels.

    Full Information

    First Posted
    January 6, 2023
    Last Updated
    August 16, 2023
    Sponsor
    Duke University
    Collaborators
    National Institutes of Health (NIH)
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05686122
    Brief Title
    Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings (PainPac)
    Official Title
    Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    January 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    September 18, 2023 (Anticipated)
    Primary Completion Date
    March 31, 2025 (Anticipated)
    Study Completion Date
    March 31, 2025 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Duke University
    Collaborators
    National Institutes of Health (NIH)

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    PainPac is innovative in its potential to integrate with healthcare systems through electronic medical records (EMRs). PainPac leverages technology to increase patient access to interventions and uses real-time assessment to improve care. PainPac is positioned to rapidly provide improved care through combining biological data (e.g., EMRs, patient collected) with behavioral data to dramatically improve outcomes. PainPac could track beneficial outcomes related to clinical pain scores (e.g., patients with scores 4-8 benefit) and intervention implementation could be based on this; a more advanced possibility is use of geospatial tracking to predict space/time where pain is likely to impact functioning and push an intervention strategy - behavioral or pharmacological. PainPac is designed for future transmission of data to EMRs to inform providers of patient status. This work will provide data to bypass traditional efficacy trials and move quickly to a large effectiveness trial.
    Detailed Description
    The investigators will use a pilot RCT to examine PainPac feasibility, patient burden, engagement, acceptability, and initial pain-related outcomes, compared to a therapist led videoconference delivered behavioral pain intervention (PCST-Video) in colorectal cancer patients with pain. Investigators will use quantitative and qualitative data to optimize PainPac. Participants will complete assessments at pre-treatment (A1), post-treatment (A2; 4 weeks post-A1), and 1 month follow-up (A3; 1 month post-A2) (months 5-22). The pain management strategies are relevant and efficacious across cancer types. Due to the pilot nature of this work, investigators will enroll an opportunity sample of colorectal cancer patients. PainPac is a patient-focused intervention developed using cognitive-behavioral theory and empirically supported strategies to enhance patients' ability to manage their pain. PainPac is a mobile app available to participants on a smartphone or tablet. PainPac uses Social Cognitive Theory to promote behaviors to improve pain, self-efficacy for pain management, and pain-related quality of life indices. It also uses real-time data to personalize the intervention and messaging to participants. PainPac contains 4 modules, each including a skill that has shown efficacy for reducing pain in patients with cancer. Patients are prompted to complete one module each week for 4 weeks. The app also has interactive components to improve coping skills engagement. Participants randomized to PCST-Video will receive 4 behavioral cancer pain intervention sessions delivered by videoconferencing by a pain therapist in the medical center to the patient in their natural environment (e.g., home). Sessions will be scheduled weekly for 45-60 min and mimic in person sessions. PCST-Video session content is matches the PainPac skills modules described above. PCST-Video participants will complete assessments at the same intervals as PainPac participants. Aim 1: Test whether PainPac is feasible (primary aim), low burden, engaging, and acceptable. Aim 2: Examine the impact of PainPac on pain severity, pain interference, pain self-efficacy, and quality of life. Aim 3: Gather quantitative and qualitative post-treatment data on patients' preferences, barriers, and facilitators regarding PainPac to update and optimize PainPac for a future large randomized clinical effectiveness trial.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Colorectal Cancer
    Keywords
    cancer, pain, coping, mHealth, symptom management

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    60 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    PainPac
    Arm Type
    Experimental
    Arm Description
    4 behavioral cancer pain intervention sessions delivered by mobile application. Patient-focused intervention. PainPac uses Social Cognitive Theory to promote behaviors to improve pain, self-efficacy for pain management, and pain-related quality of life indices. It also uses real-time data to personalize the intervention and messaging to participants. The app also has interactive components to improve coping skills engagement.
    Arm Title
    PCST-Video
    Arm Type
    No Intervention
    Arm Description
    4 behavioral cancer pain intervention sessions delivered by videoconferencing by a pain therapist in the medical center to the patient in their natural environment (e.g., home). Sessions will be scheduled weekly for 45-60 min and mimic in person sessions. PCST-Video session content is matches the PainPac skills modules. PCST-Video participants will complete assessments at the same intervals as PainPac participants.
    Intervention Type
    Behavioral
    Intervention Name(s)
    PainPac
    Intervention Description
    Patient-focused behavioral pain intervention delivered via mobile application.
    Primary Outcome Measure Information:
    Title
    Feasibility as measured by study accrual
    Description
    Reaching target accrual (N=60) within 15 months.
    Time Frame
    15 months
    Title
    Feasibility as measured by attrition
    Description
    <25% attrition by 1-month post-baseline.
    Time Frame
    1-month post-baseline assessment
    Title
    Feasibility as measured by the number of study baseline assessments completed
    Description
    Protocol adherence indicated by calculating the degree to which participants are willing/able to complete the study baseline assessment.
    Time Frame
    20 minutes
    Title
    Feasibility as measured by the number of post-study sessions assessments completed
    Description
    Protocol adherence indicated by calculating the degree to which participants are willing/able to complete the post-study sessions assessment.
    Time Frame
    20 minutes
    Title
    Feasibility as measured by the number of study 1-month follow up assessments completed
    Description
    Protocol adherence indicated by calculating the degree to which participants are willing/able to complete the 1-month follow up assessment.
    Time Frame
    20 minutes
    Title
    Feasibility of PainPac
    Description
    Includes protocol adherence indicated by calculating the degree to which participants are willing/able to complete the 4 PainPac skills modules or 4 PCST-Video sessions.
    Time Frame
    11 Weeks
    Secondary Outcome Measure Information:
    Title
    Acceptability as measured by the Client Satisfaction Questionnaire.
    Description
    10-item Client Satisfaction Questionnaire (CSQ). This questionnaire contains 10 items rated from 1=low acceptability to 4=high acceptability; scores are created by utilizing the Likert Scale to average Client Satisfaction Questionnaire answers resulting in a score range from 1-4. The participant will complete this acceptability questionnaire as part of the post-session follow up assessment.
    Time Frame
    20 minutes
    Title
    Acceptability as measured by Atkinson's tool of mHealth innovations.
    Description
    Atkinson's tool will also be used to assess perceived attributes of mHealth innovations. Tool has 30 items about mHealth, participant indicates their level of agreement or disagreement on a 6-point Likert scale: l=strongly agree, 2=agree, 3=somewhat agree, 4=somewhat disagree. 5=disagree, and 6=strongly disagree.
    Time Frame
    20 minutes
    Title
    PainPac Patient Preferences, Barriers, Facilitators, Attitudes, and Beliefs
    Description
    Post-intervention, measured together as one measure, patients will be asked 10 items modeled from labs previous work. Items will be answered on a 0-10 scale with 0=low preference, barrier, belief and 10=high preference, barrier, belief.
    Time Frame
    Post-Intervention Survey, 20 minutes
    Title
    Change in Computer Self-Efficacy
    Description
    Post-Intervention, 10 items on a 10 point scale from 0=not at all confident to 10=completely confident. Patients are asked 10 items regarding their confidence in ability to use technology (computer and smartphone app).
    Time Frame
    Post-Intervention Survey, 20 minutes
    Title
    Change in Pain Severity as Assessed With the Brief Pain Inventory (BPI)
    Description
    Pain will be assessed with the Brief Pain Inventory (BPI). Patients will rate their "worst", "least", "average", and "now" pain from 0=no pain to 10=worst pain imaginable. An average of the responses to these items is used to create a single pain severity score.
    Time Frame
    11 weeks
    Title
    Pain Interference as Assessed With the Brief Pain Inventory (BPI) - Pain Interference Scale
    Description
    Pain interference will be assessed with the Brief Pain Inventory (BPI) - Pain Interference Scale. Patients will rate how much pain interfered with a variety of activities and mood states over the last 7 days from 0=does not interfere to 10=completely interferes. An average of the responses to these items is used to create a single pain severity score.
    Time Frame
    11 weeks
    Title
    Change in Pain Self-Efficacy for Pain Management
    Description
    5-item self-efficacy subscale of the Chronic Pain Self-Efficacy Scale. Items ask about patients' certainty about pain control, pain during activities, and reducing pain without extra medication using a 10=very uncertain to 100=very certain scale and averaged. The 10-item Computer Self-Efficacy Scale will be used to ask about patients' confidence in using technology to receive a behavioral pain intervention.
    Time Frame
    11 weeks
    Title
    Change in Patient Burden
    Description
    12-item measure developed in the lab through a NCI study examining burdens with accessing care after a cancer diagnosis. Patients will rate difficulty completing the intervention (PainPac modules or PCST-Video sessions) on a 1=not at all to 5=very much scale based on physical, emotional, financial burdens. A summated scale will be used to assess internal validity using Cronbach's alpha of 0.75.
    Time Frame
    11 Weeks
    Title
    Engagement in Study
    Description
    Engagement is defined as the number of times/week participants log into PainPac and practice the skills. Engagement will be assessed based on app data and patient self-report. Patient Engagement will be assessed by electronic app data (e.g., PainPac weekly log-ins) and patient self-report defined as the number of times per week they practice the coping skills. >3 times/week will serve as the benchmark; if participants log into PainPac and/or practice the coping skills <3 times/week, PainPac will not be considered engaging.
    Time Frame
    11 Weeks
    Title
    Change in Quality of Life
    Description
    Centers for Disease Control Health Related Quality of Life 14-item measure. This measure assesses healthy days in the last month and activity limitations and symptoms.
    Time Frame
    11 Weeks
    Title
    Change in PROMIS - Emotional Distress (Depression) Short Form
    Description
    Post-intervention and 1-month follow up, 8 items on a 5 point scale from 1=never, 2=rarely, 3=sometimes, 4=often, 5=always. Patients are asked 8-items regarding "in the past 7 days I felt..." to assess their emotional distress levels.
    Time Frame
    11 weeks

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    110 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Stage I-IV Colorectal Cancer diagnosis 18 years of age or older Exclusion Criteria: Cognitive Impairment Brain Metastases Severe psychiatric condition (e.g., psychosis) that would contraindicate safe participation Participation in behavioral pain management in the past 6 months.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Sarah A Kelleher, PhD
    Phone
    919-416-3405
    Email
    sarah.kelleher@duke.edu
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Sarah A Kelleher, PhD
    Organizational Affiliation
    Duke University
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings (PainPac)

    We'll reach out to this number within 24 hrs